MARKET

PSTV

PSTV

Plus Therapeutics Inc
NASDAQ
4.200
-0.060
-1.41%
After Hours: 4.160 -0.04 -0.95% 19:41 06/26 EDT
OPEN
4.250
PREV CLOSE
4.260
HIGH
4.450
LOW
4.130
VOLUME
286.15K
TURNOVER
--
52 WEEK HIGH
23.43
52 WEEK LOW
2.900
MARKET CAP
28.91M
P/E (TTM)
-1.6826
1D
5D
1M
3M
1Y
5Y
1D
Plus Subsidiary CNSide Signs Agreement With Elevance For CNSide Assay Test For CNS Metastasis
NASDAQ · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
Reuters · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
Reuters · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE-Wendy's, Canadian Solar, Bio-Techne
Reuters · 3d ago
Plus Therapeutics wins Elevance Health coverage deal
Seeking Alpha · 3d ago
BUZZ-Plus Therapeutics up after unit signs deal with Elevance Health for cancer test
Reuters · 3d ago
CNSide Diagnostics Strikes Deal With Elevance Health To Offer CNSide Cerebrospinal Fluid Tumor Cell Enumeration Assay, Effective May 1, 2026
Benzinga · 3d ago
Plus Therapeutics unit CNSide signs national coverage deal with Elevance Health for CSF cancer assay
PUBT · 3d ago
More
About PSTV
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system. Combining image-guided local beta radiation and targeted drug delivery approaches, it is advancing a pipeline of product candidates with lead programs in leptomeningeal metastases (LM) and recurrent glioblastoma (GBM). Its lead radiotherapeutic candidate, REYOBIQ (rhenium (186Re) obisbemeda), is designed specifically for CNS cancers including GBM, LM, and pediatric brain cancers (PBC) by direct localized delivery utilizing approved standard-of-care tissue access such as with convection-enhanced delivery (CED) and intraventricular brain (Ommaya reservoir) catheters. Its radiotherapeutic candidate, Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere (188RNL-BAM), is designed to treat many solid organ cancers including primary and secondary liver cancers via intra-arterial injections.

Webull offers Plus Therapeutics Inc (USA) stock information, including NASDAQ: PSTV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSTV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSTV stock methods without spending real money on the virtual paper trading platform.